We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9024:TSESeibu Holdings, Inc. Analysis

Data as of 2026-03-14 - not real-time

¥4,154.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Seibu Holdings (9024.T) is trading at ¥4,154, well below its 20‑day (¥4,435) and 50‑day (¥4,328) simple moving averages, indicating a short‑term downtrend, while the 14‑day RSI of 35.9 suggests the stock is approaching oversold territory. The MACD histogram remains deeply negative (‑50.8) and the MACD signal is bearish, reinforcing downside momentum, yet the price sits near a key support level around ¥4,042 and volume has been decreasing, pointing to waning buying interest. On the valuation side, the trailing PE of 5.75 is dramatically lower than the industry average of 29.1, and the price‑to‑book of 1.94 implies a discount relative to book value, but the forward PE jumps to 29.5, reflecting a steep earnings decline forecast. Recent nine‑month results show net income falling from ¥91.36 B to ¥32.09 B, underscoring earnings pressure that drives the forward EPS downgrade from ¥722 to ¥141.
The balance sheet is heavily leveraged with a debt‑to‑equity of 118.6% and net debt far exceeding cash reserves, though the company generates robust ROE (42%) and profit margins (21.9%). Dividend yield sits at 0.96% with a modest payout ratio of 6.2%, suggesting sustainability despite cash‑flow reporting anomalies. Volatility is high at 27% over 30 days, but beta remains low (≈0.3), indicating limited market‑wide correlation. Overall, the stock appears undervalued from a value perspective but carries medium‑to‑high financial and operational risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above the identified support level (¥4,042)
  • Bearish MACD and decreasing trading volume
  • RSI indicating potential oversold condition

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (PE 5.75 vs industry 29.1)
  • Low dividend payout ratio supporting cash return sustainability
  • Target median price (~¥4,600) offering upside potential

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • High ROE (42%) and strong profit margins
  • Stable dividend yield with ample earnings coverage
  • Low market beta suggesting defensive characteristics in a diversified portfolio

Key Metrics & Analysis

Financial Health

Revenue Growth-0.10%
Profit Margin21.90%
P/E Ratio5.8
ROE42.20%
ROA10.87%
Debt/Equity118.58
P/B Ratio1.9
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI35.9
Support¥4,042.00
Resistance¥4,775.00
MA 20¥4,435.55
MA 50¥4,327.90
MA 200¥4,740.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Target Price¥4,070.00
Upside/Downside-2.02%
GradeUndervalued
TypeValue
Dividend Yield0.96%

Risk Assessment

Beta0.29
Volatility27.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.